Stock Analysis·← Pickers

LMRI

Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is currently in a range/mixed trend. RSI is at 53.2, with 1/3 trend checks passing.

Price
$11.02
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
53.2
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

LMRI with MA50 and MA200

18.5315.5912.659.716.7712/1102/0503/3005/2107/15
LMRI2025-12-112026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$9.53+15.69% vs price
MA200
Distance unavailable
RSI (14)
53.2Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for LMRI

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $11.02, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 15.7%.

Momentum and stretch context

LMRI currently has an RSI reading of 53.2, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the LMRI chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

Sector
Healthcare
Industry
Medical - Devices
CEO
Caitlin Zulla
Market cap
$1.06B
Beta
0.99
52-week range
$6.45 – $19.45
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
11 Dec 2025
ISIN
US5502491062
CUSIP
550249106
Company profile data from Financial Modeling Prep. LMRI listed on NASDAQ.
Share dilution

LMRI shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Dec 2024Mar 2026
Shares outstanding (latest)
96.0M
Since Dec 2024
+1.5%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. LMRI3 data points from Dec 2024 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about LMRI

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.